Lupin Diagnostics is the diagnostics arm of pharma major Lupin Limited , operating a pan‑India network of laboratories and collection centres on a hub‑and‑spoke model. The company runs a state‑of‑the‑art 45,000 sq ft National Reference Laboratory in Navi Mumbai, supported by regional reference labs, satellite labs, and over 600 collection centres across East, West, Central, and South India.
The network offers more than 2,500–3,000 tests spanning molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology, and routine biochemistry, along with extensive preventive health packages for all age groups. Lupin Diagnostics emphasizes stringent quality control, temperature‑controlled logistics, real‑time phlebotomist tracking, and patient‑friendly “smart reports” to ensure accuracy and convenience.
Key services & capabilities
-
Comprehensive test menu
-
2,500+ to 3,000+ routine and advanced tests across molecular diagnostics, histopathology, cytology, microbiology, serology, haematology, immunology, and clinical biochemistry.
-
-
Network & access model
-
Hub‑and‑spoke structure with National Reference Lab in Navi Mumbai, multiple regional reference labs (e.g., Indore for Central India, Chennai for South India, Guwahati for North‑East), satellite labs, and 600+ collection centres.
-
Services include collection centres, pick‑up points, hospital and retail lab management, and home sample collection (“LupiMitra” franchise network in some regions).
-
-
Home sample collection & digital experience
-
Free home collection via 500+ trained phlebotomists, with real‑time phlebo tracking and temperature‑controlled logistics (200+ logistics executives).
-
Online booking of lab tests and health packages, digital reports, and integration with partner platforms such as SecondMedic and other health aggregators.
-
Quality & accreditation
-
All processing laboratories run directly by Lupin Diagnostics with centralized quality systems and adherence to NABL and CAP guidelines.
-
By April 2025, all greenfield labs achieved 100% NABL accreditation, reinforcing the network’s focus on high‑quality, evidence‑based diagnostics.
Achievements & expansion highlights
-
Operations started in October 2021 and scaled rapidly to 36+ laboratories and 600+ collection centres across India by 2025.
-
Regional reference laboratories launched in Indore (Central India), Guwahati (North‑East), and Chennai (South India), each capable of handling a broad spectrum of advanced tests.
-
Recognized for stringent quality control, smart reports, and patient‑centric service, positioning Lupin Diagnostics among the prominent national diagnostics players.
